E&S HEALTHCARE Trademark

Trademark Overview


On Wednesday, July 1, 2020, a trademark application was filed for E&S HEALTHCARE with the United States Patent and Trademark Office. The USPTO has given the E&S HEALTHCARE trademark a serial number of 90031610. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, May 8, 2024. This trademark is owned by E&S Healthcare Co., Ltd.. The E&S HEALTHCARE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Diagnostic reagents for medical use for immune disease; diagnostic reagents for medical use; medical diagnostic reagents; diagnostic reagents for medical or veterinary purposes; immunoassay diagnostic reagents for medical purposes; biological reagents for medical diagnostic purposes; reagents for medical diagnostic purposes for the analysis of body fluids; reagent paper for medical purposes; medicated lozenges; chemical reagents for medical purposes; diagnostic reagents for medicinal use; clinical medical reagents; clinical diagnostic reagents in the nature of clinical medical reagents

Medical device for detecting cancer; medical device, namely, in vitro diagnostic medical device; test equipment for medical use, namely, a breast cancer diagnostic kit comprised of anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus for detecting cancer and testing for viruses; apparatus for blood testing for medical use; medical device and apparatus in the field of clinical diagnosis, namely, a breast cancer diagnostic kit comprised of anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; testing instruments for medical diagnostic purposes, namely, a breast cancer diagnostic kit comprised of anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; tools for medical diagnostics, namely, a breast cancer diagnostic kit comprised of anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 cali...
e&s healthcare

General Information


Serial Number90031610
Word MarkE&S HEALTHCARE
Filing DateWednesday, July 1, 2020
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, May 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic reagents for medical use for immune disease; diagnostic reagents for medical use; medical diagnostic reagents; diagnostic reagents for medical or veterinary purposes; immunoassay diagnostic reagents for medical purposes; biological reagents for medical diagnostic purposes; reagents for medical diagnostic purposes for the analysis of body fluids; reagent paper for medical purposes; medicated lozenges; chemical reagents for medical purposes; diagnostic reagents for medicinal use; clinical medical reagents; clinical diagnostic reagents in the nature of clinical medical reagents
Pseudo MarkE AND S HEALTHCARE
NOT AVAILABLE"HEALTHCARE"
Goods and ServicesMedical device for detecting cancer; medical device, namely, in vitro diagnostic medical device; test equipment for medical use, namely, a breast cancer diagnostic kit comprised of anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus for detecting cancer and testing for viruses; apparatus for blood testing for medical use; medical device and apparatus in the field of clinical diagnosis, namely, a breast cancer diagnostic kit comprised of anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; testing instruments for medical diagnostic purposes, namely, a breast cancer diagnostic kit comprised of anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; tools for medical diagnostics, namely, a breast cancer diagnostic kit comprised of anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; blood analysis apparatus for diagnosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameE&S Healthcare Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDaejeon 34015
KR

Trademark Events


Event DateEvent Description
Saturday, July 4, 2020NEW APPLICATION ENTERED
Wednesday, July 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Tuesday, October 13, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 13, 2020NON-FINAL ACTION E-MAILED
Tuesday, October 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 26, 2021SUSPENSION LETTER WRITTEN
Thursday, October 14, 2021SUSPENSION INQUIRY WRITTEN
Friday, March 26, 2021LETTER OF SUSPENSION E-MAILED
Friday, March 26, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 13, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, October 14, 2021INQUIRY TO SUSPENSION E-MAILED
Thursday, October 14, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, April 14, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, April 18, 2022ASSIGNED TO LIE
Thursday, April 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 10, 2022SUSPENSION LETTER WRITTEN
Tuesday, May 10, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, May 10, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 5, 2022SUSPENSION INQUIRY WRITTEN
Monday, December 5, 2022INQUIRY TO SUSPENSION E-MAILED
Monday, December 5, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, March 2, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 9, 2023ASSIGNED TO LIE
Thursday, March 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 10, 2023SUSPENSION LETTER WRITTEN
Friday, March 10, 2023LETTER OF SUSPENSION E-MAILED
Friday, March 10, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 26, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, September 26, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, September 26, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, January 23, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 23, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 23, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, February 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 22, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 26, 2024ASSIGNED TO PETITION STAFF
Tuesday, March 26, 2024PETITION GRANTED - RESPONSE RECEIVED
Tuesday, March 26, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, March 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 8, 2024FINAL REFUSAL WRITTEN
Wednesday, May 8, 2024FINAL REFUSAL E-MAILED
Wednesday, May 8, 2024NOTIFICATION OF FINAL REFUSAL EMAILED